Products for Research Use Only
RegisterLogin

SARS-CoV-2-IN-13

CAT: 0013-GTR19243947-01Size: 500 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19243947-01Size:500 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SARS-CoV-2-IN-13 (compound 5) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.057 μM. SARS-CoV-2-IN-13 is a niclosamide analogue. SARS-CoV-2-IN-13 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally.
CAS Number
56961-10-5
Field of Research
Infectious Disease & Virology
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : ≥ 125 mg/mL (382.12 mM)
Smiles
Oc1ccc (Cl) cc1C (=O) Nc1ccc (c (Cl) c1) [N+] ([O-]) =O
Molecular Formula
C13H8Cl2N2O4
Molecular Weight
327.12
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.

Related Products

CatalogName
GTR19261808-01SARS-CoV-2 Mpro-IN-13
GTR19220908-01SARS-CoV-2 3CLpro-IN-13
GTR18678023-01SARS-CoV/SARS-CoV-2 Spike Antibody
GTR18678025-01SARS-CoV/SARS-CoV-2 Spike Antibody
GTR19204850-01SARS-CoV-IN-2
GTR18148257SARS-CoV-2
GTR18595045-01SARS CoV/SARS CoV 2 Spike Human mAb
GTR19219261-01SARS-CoV-2-IN-67
GTR19219258-01SARS-CoV-2-IN-64
GTR19213594-01SARS-CoV-2-IN-39

Alternative Products

CatalogName
BA2293-5.1SARS-CoV-2-IN-13
HY-163186SARS-CoV-2 Mpro-IN-13
HY-149264-01SARS-CoV-2 3CLpro-IN-13
abx620060-01SARS-CoV-2 Non-Structural Protein 13
MBS4754235-01SARS-CoV/SARS-CoV-2 Spike antibody
BA1949-5SARS-CoV-IN-2
553226SARS-CoV-2
Oneq-S827-150RSARS CoV-2

Popular Products